Lv41
490 积分 2024-10-23 加入
Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance
1小时前
已完结
Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma
1小时前
已完结
Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
2小时前
已完结
Linking tumour angiogenesis and tumour immunity
2小时前
已完结
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
2小时前
已完结
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
2小时前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2小时前
已完结
Sorafenib in Advanced Hepatocellular Carcinoma
2小时前
已完结
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2小时前
已完结
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
2小时前
已完结
皖公网安备34019202002308
